The Central and Eastern Europe Fund, Inc. is a closed ended equity mutual fund launched by Deutsche Investment Management Americas Inc. The fund is managed by Deutsche Asset Management International GmbH. It invests in the public equity markets across Central and Eastern Europe. The fund seeks to invest in stocks of companies operating across diversified sectors. It benchmarks the performance of its portfolio against the CECE, RTX, and ISE National 30. The fund was formerly known as The Central Europe And Russia Fund, Inc. The Central and Eastern Europe Fund, Inc. was formed on March 6, 1990 and is domiciled in the United States.
IPO Year:
Exchange: NYSE
Website: fundsus.deutscheam.com/EN/products/central-eastern-euro
| Date | Price Target | Rating | Analyst |
|---|
4/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
RBC Capital reiterated coverage of Centamin with a rating of Sector Perform and set a new price target of $115.00 from $128.00 previously
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
3 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
N-PX - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
N-CSRS - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
DEFA14A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
NPORT-P - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
DEF 14A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
NPORT-P - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
N-CEN - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
N-CSR - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
NPORT-P - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
40-17G - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
The Central and Eastern Europe Fund, Inc. (NYSE:CEE) (the "Fund"). As previously reported, certain of the Fund's Russian holdings have been valued at zero since March 14, 2022 in light of measures adopted by the Russian Central Bank and Government, as well as sanctions implemented by the United States and other countries in response to Russia's invasion of Ukraine. The effects of the sanctions and measures adopted by the Russian Central Bank and Government are far-reaching and include, among others, the freezing of certain Russian assets held by entities, such as the Fund, that are organized in countries viewed as "unfriendly" by the Russian Government. The Fund's investment manager has b
The Central and Eastern Europe Fund, Inc. (NYSE:CEE) (the "Fund"). As previously reported, certain of the Fund's Russian holdings have been valued at zero since March 14, 2022 in light of measures adopted by the Russian Central Bank and Government, as well as sanctions implemented by the United States and other countries in response to Russia's invasion of Ukraine. The effects of the sanctions and measures adopted by the Russian Central Bank and Government are far-reaching and include, among others, the freezing of certain Russian assets held by entities, such as the Fund, that are organized in countries viewed as "unfriendly" by the Russian Government. The Fund's investment manager has be
The Central and Eastern Europe Fund, Inc. (NYSE:CEE), The European Equity Fund, Inc. (NYSE:EEA), and The New Germany Fund, Inc. (NYSE:GF) (each, a "Fund," and collectively, the "Funds") each announced today that its Board of Directors has approved an extension of the current repurchase authorization permitting open market share repurchase program for an additional twelve-month period. Each Fund may continue to purchase outstanding shares of its common stock in open-market transactions over the twelve-month period from August 1, 2024 through July 31, 2025 when the Fund's shares trade at a discount to net asset value ("NAV") and such purchases are deemed to be in the best interests of the Fun
The Central and Eastern Europe Fund, Inc. (NYSE:CEE) (the "Fund") announced today the results of its Annual Meeting of Stockholders which was initially called to order and adjourned on June 27, 2024 and reconvened on July 19, 2024. Both of the two Class III Directors nominated by the Board of Directors, Dr. Holger Hatje and Dr. Wolfgang Leoni, were elected at the reconvened meeting, to serve for a term of three years and until his respective successor is elected and qualifies. The Fund previously announced that, prior to the adjournment of the meeting on June 27, 2024, stockholders ratified the appointment of Ernst & Young LLP as the independent auditors for the Fund for its 2024 fiscal
The Central and Eastern Europe Fund, Inc. (NYSE:CEE) (the "Fund") announced today the results of its Annual Meeting of Stockholders held on June 27, 2024. Stockholders ratified the appointment of Ernst & Young LLP as the independent auditors for the Fund for its 2024 fiscal year. The nominees for election as directors of the Fund had not received sufficient votes to be elected. Therefore, the meeting was adjourned to July 19, 2024 at 2:00 p.m. at the offices of DWS Investment Management Americas, Inc., 875 Third Avenue, New York, NY in order to allow more time to solicit proxies. In addition, the Fund announced today that the Fund's investment advisor, DWS International GmbH, has volu
The Central and Eastern Europe Fund, Inc. (NYSE:CEE) (the "Fund"). As previously reported, the Fund's Russian holdings have been valued at zero since March 14, 2022 in light of measures adopted by the Russian Central Bank and Government, as well as sanctions implemented by the United States and other countries in response to Russia's invasion of Ukraine. The effects of the sanctions and measures adopted by the Russian Central Bank and Government are far-reaching and include, among others, the freezing of certain Russian assets held by entities, such as the Fund, that are organized in countries viewed as "unfriendly" by the Russian Government. The Fund's investment manager has been monitorin
The Central and Eastern Europe Fund, Inc. (NYSE:CEE) and The New Germany Fund, Inc. (NYSE:GF) (each, a "Fund," and, collectively, the "Funds") announced today that the Annual Meeting of Stockholders for each Fund will be held at 10:00 a.m., Eastern time on June 27, 2024 at the offices of DWS Investment Management Americas, Inc., 875 Third Avenue, New York, New York 10022. Holders of shares of common stock of record of the Funds at the close of business on May 2, 2024 are entitled to vote at the meeting and any postponements or adjournments thereof. At the meeting, stockholders of each Fund will consider the election of Directors and approval of auditors. Important Information The Centra
The Central and Eastern Europe Fund, Inc. (NYSE:CEE), The New Germany Fund, Inc. (NYSE:GF) and The European Equity Fund, Inc. (NYSE:EEA) (each, a "Fund," and collectively, the "Funds") each announced today that its Board of Directors declared the distributions set forth below. CEE's and EEA's total distributions will be paid in stock except that any stockholder of record as of December 29, 2023 may elect to receive such distribution in cash. GF's total distributions will be paid in cash to the stockholders of record as of December 29, 2023. Details for each Fund's 2023 yearly December distributions are as follows: Declaration- 12/19/2023 Ex-Date- 12/28/2023 Record- 12/29/202
The Central and Eastern Europe Fund, Inc. (NYSE:CEE), The European Equity Fund, Inc. (NYSE:EEA) and The New Germany Fund, Inc. (NYSE:GF) (each, a "Fund," and collectively, the "Funds") each announced today that, in connection with the previously announced retirements of Mr. Christian Strenger and Dr. Christopher Pleister from each Fund's Board, the Board of Directors has appointed Mr. Bernhard Koepp, Independent Director of each Fund, to succeed Mr. Christian Strenger as the Chairman of each Fund's Board effective January 1, 2024, rather than Mr. Walter C. Dostmann, as previously announced. Mr. Dostmann will continue to serve as a Director for the Funds. The Boards thanks Mr. Strenger and
The Central and Eastern Europe Fund, Inc. (NYSE:CEE), The European Equity Fund, Inc. (NYSE:EEA), and The New Germany Fund, Inc. (NYSE:GF) (each, a "Fund," and collectively, the "Funds") each announced today that its Board of Directors has approved an extension of the current repurchase authorization permitting CEE, EEA, GF and to repurchase up to 630,039, 687,213 and 1,710,430 shares, respectively (representing approximately 10% of each Fund's current shares outstanding) for the twelve month period from August 1, 2023 through July 31, 2024. Repurchases will be made from time to time when they are believed to be in the best interests of a Fund. Repurchases will not be made when a Fund's shar
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. • InflaRx (NASDAQ:IFRX) is projected to report quarterly loss at $0.20 per share on revenue of $1.42 million. • Fennec Pharmaceuticals (NASDAQ:FENC) is likely to report quarterly loss at $0.02 per share on revenue of $8.67 million. • Welltower (NYSE:WELL) is likely to report quarterly earnings at $0.00 per share on revenue of $218.97 million. • VerifyMe (NASDAQ:VRME) is expected to report quarterly loss at $0.03 per share on revenue of $8.95 million. • Academy Sports (NASDAQ:ASO) is expected to report quarterly earnings at $2.2
Endeavour Mining (LSE: EDV) announced the abrupt termination of CEO Sébastien de Montessus, citing "serious misconduct" and irregularities linked to the sale of a company asset. Following the news, shares dropped by 14% before erasing some losses during the Friday session. Endeavour is a constituent of the FTSE 100 Index while also listed on the Toronto Stock Exchange. According to a statement, the London-based company took decisive action after uncovering an alleged “irregular payment instruction” amounting to $5.9 million related to an asset sale. Additionally, an external investigation into de Montessus’s conduct with colleagues, prompted by allegations from October, led to
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million. • ImmunoPrecise Antibodies (NASDAQ:IPA) is projected to report quarterly loss at $0.17 per share on revenue of $3.96 million. • Blue Apron Hldgs (NYSE:APRN) is expected to report quarterly loss at $0.83 per share on revenue of $100.13 million. • Yiren Digital (NYSE:YRD) is estimated to report earnings for its second quarter. • KE Holdings (NYSE:BEKE) is likely to report quarterly earnings at $0.08 per share on revenue of $2.29 billion. • Hello Gr (NASDAQ:MOMO) is projected to report quarterly earnings at $0.29 per share on revenue
During Wednesday's trading, 517 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to set a new 52-week low. SenesTech (NASDAQ:SNES) was the smallest firm by market cap to set a new 52-week low. Kinnate Biopharma (NASDAQ:KNTE) shares traded down 33.88% to reach its 52-week low, making it the biggest loser. AT&T (NYSE:T)'s shares had the biggest turnaround, impressively rebounding 0.0% after reaching a new 52-week low. The following stocks set new 52-week lows on Wednesday: Microsoft (NASDAQ:MSFT) stock set a new 52-week low of $223.96 on Wednesday, moving up 0.01%. JPMorgan Chase
On Monday, 524 stocks hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Taiwan Semiconductor (NYSE:TSM). ThermoGenesis Holdings (NASDAQ:THMO) was the smallest, in terms of market cap, to set a new 52-week low. Incannex Healthcare (NASDAQ:IXHL)'s stock made the biggest move downwards, diving 18.56% to reach a new 52-week low. On Monday, the following stocks broke to new 52-week lows: Taiwan Semiconductor (NYSE:TSM) shares set a new yearly low of $100.78 this morning. The stock was down 3.51% on the session. JPMorgan Chase (NYSE:JPM) stock dropped to a yearly low on Monday of $129.24. Shares trad
Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by market cap to set a new 52-week low. Mobiquity Technologies (NASDAQ:MOBQ) was the smallest company by market cap to set a new 52-week low. SAB Biotherapeutics (NASDAQ:SABS)'s stock came under the most pressure, trading down 52.51% to reach a new 52-week low. Neenah (NYSE:NP)'s shares had the biggest turnaround, impressively rebounding 0.0% after reaching a new 52-week low. Over the course of trading on Wednesday, the following stocks hit new 52-week lows: Citigroup (NYSE:C) shares reached a new 52-week low of $55.93 on Wedne
During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the largest, in terms of market cap, to set a new 52-week low. The smallest company by market cap to hit a new 52-week low was Yumanity Therapeutics (NASDAQ:YMTX). GoodRx Holdings (NASDAQ:GDRX) saw the most significant move of the companies, as shares traded down 40.47% to reach its new 52-week low. Maiden Holdings (NASDAQ:MHLD) shares rebounded the highest, with shares trading up 0.0%, bouncing back after reaching its new 52-week low. These stocks set new 52-week lows on Tuesday: JPMorgan Chase (NYSE:JPM) stock dropped to a yearl
On Monday morning, 66 companies achieved new lows for the year. Noteable 52-Week Lows: Gilead Sciences (NASDAQ:GILD) was the largest firm on a market cap basis to set a new 52-week low. Tenax Therapeutics (NASDAQ:TENX) was the smallest company when considering market cap to set a new 52-week low. Esports Entertainment (NASDAQ:GMBL) was the biggest loser of the morning session, as it dropped 34.48% to reach its new 52-week low. Morgan Stanley Emerg Mkts (NYSE:MSD) shares were the most resilient of the group, as shares actually moved up 0.58% in response to hitting its 52-week low. The following stocks achieved new 52-week lows during the first half-hour of trading on Monday: Gi